These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1550698)

  • 21. Detection of autoantibody to aldolase B in sera from patients with troglitazone-induced liver dysfunction.
    Maniratanachote R; Shibata A; Kaneko S; Yamamori I; Wakasugi T; Sawazaki T; Katoh K; Tokudome S; Nakajima M; Yokoi T
    Toxicology; 2005 Dec; 216(1):15-23. PubMed ID: 16115720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors affecting the expression of trifluoroacetylated liver microsomal protein neoantigens in rats treated with halothane.
    Kenna JG; Martin JL; Satoh H; Pohl LR
    Drug Metab Dispos; 1990; 18(5):788-93. PubMed ID: 1981738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patients with delayed-onset sulfonamide hypersensitivity reactions have antibodies recognizing endoplasmic reticulum luminal proteins.
    Cribb AE; Pohl LR; Spielberg SP; Leeder JS
    J Pharmacol Exp Ther; 1997 Aug; 282(2):1064-71. PubMed ID: 9262376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new anti-liver-kidney microsome antibody (anti-LKM2) in tienilic acid-induced hepatitis.
    Homberg JC; Andre C; Abuaf N
    Clin Exp Immunol; 1984 Mar; 55(3):561-70. PubMed ID: 6368059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predisposition to phenytoin hepatotoxicity assessed in vitro.
    Spielberg SP; Gordon GB; Blake DA; Goldstein DA; Herlong HF
    N Engl J Med; 1981 Sep; 305(13):722-7. PubMed ID: 6790991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypersensitivity syndrome induced by anticonvulsants: possible cross-reactivity between carbamazepine and lamotrigine.
    Aouam K; Ben Romdhane F; Loussaief C; Salem R; Toumi A; Belhadjali H; Chaabane A; Boughattas NA; Chakroun M
    J Clin Pharmacol; 2009 Dec; 49(12):1488-91. PubMed ID: 19723672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic disorders associated with liver-kidney microsomal antibodies.
    Smith MG; Williams R; Walker G; Rizzetto M; Doniach D
    Br Med J; 1974 Apr; 2(5910):80-4. PubMed ID: 4596402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrosomal antibodies: what are they telling us?
    Watkins PB
    Hepatology; 1991 Feb; 13(2):385-7. PubMed ID: 1995447
    [No Abstract]   [Full Text] [Related]  

  • 29. Metabolic detoxification determines species differences in coumarin-induced hepatotoxicity.
    Vassallo JD; Hicks SM; Daston GP; Lehman-McKeeman LD
    Toxicol Sci; 2004 Aug; 80(2):249-57. PubMed ID: 15141102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease.
    Manns MP; Obermayer-Straub P
    Hepatology; 1997 Oct; 26(4):1054-66. PubMed ID: 9328334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absence of anti-trifluoroacetate antibody after halothane anaesthesia in patients exhibiting no or mild liver damage.
    Sakaguchi Y; Inaba S; Irita K; Sakai H; Nawata H; Takahashi S
    Can J Anaesth; 1994 May; 41(5 Pt 1):398-403. PubMed ID: 8055607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe adverse reaction to carbamazepine: significance of humoral and cellular reactions to the drug.
    Horneff G; Lenard HG; Wahn V
    Neuropediatrics; 1992 Oct; 23(5):272-5. PubMed ID: 1454149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect of phenobarbital and amidopyrine on the rate of decomposition of isoforms of cytochrome P-450 in mouse liver microsomes].
    Adrianov NV; Dovgiĭ AI; Khaĭlov PM
    Biokhimiia; 1989 Jul; 54(7):1120-5. PubMed ID: 2804167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug rash with eosinophilia and systemic symptoms induced by valproate and carbamazepine: formation of circulating auto-antibody against 190-kDa antigen.
    Yun SJ; Lee JB; Kim EJ; Quan G; Kim SJ; Won YH; Lee SC
    Acta Derm Venereol; 2006; 86(3):241-4. PubMed ID: 16710584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypersensitivity immune reaction as a mechanism for dilevalol-associated hepatitis.
    Maria VA; Victorino RM
    Ann Pharmacother; 1992; 26(7-8):924-6. PubMed ID: 1504402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microsomal metabolism of carbamazepine and oxcarbazepine in liver and placenta.
    Myllynen P; Pienimäki P; Raunio H; Vähäkangas K
    Hum Exp Toxicol; 1998 Dec; 17(12):668-76. PubMed ID: 9988371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-liver microsomes autoantibodies and dihydralazine-induced hepatitis: specificity of autoantibodies and inductive capacity of the drug.
    Bourdi M; Gautier JC; Mircheva J; Larrey D; Guillouzo A; Andre C; Belloc C; Beaune PH
    Mol Pharmacol; 1992 Aug; 42(2):280-5. PubMed ID: 1513326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunochemical detection and quantitation of microsomal cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate:cytochrome P-450 reductase in the rat ventral prostate.
    Haaparanta T; Halpert J; Glaumann H; Gustafsson JA
    Cancer Res; 1983 Nov; 43(11):5131-7. PubMed ID: 6413054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenobarbital hepatotoxicity in an 8-month-old infant.
    Roberts EA; Spielberg SP; Goldbach M; Phillips MJ
    J Hepatol; 1990 Mar; 10(2):235-9. PubMed ID: 2332596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenetic analyses of carbamazepine-induced liver injury in F344 rats focused on immune- and inflammation-related factors.
    Sasaki E; Iida A; Oda S; Tsuneyama K; Fukami T; Nakajima M; Yokoi T
    Exp Toxicol Pathol; 2016 Jan; 68(1):27-38. PubMed ID: 26391595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.